Insider Transactions in Q3 2023 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
831
-0.2%
|
$11,634
$14.16 P/Share
|
|
Sep 28
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
568
-0.45%
|
$7,952
$14.16 P/Share
|
|
Sep 28
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
659
-0.24%
|
$9,226
$14.16 P/Share
|
|
Sep 28
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
464
-0.39%
|
$6,496
$14.16 P/Share
|
|
Sep 24
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
290
+0.07%
|
-
|
|
Sep 24
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
260
+0.21%
|
-
|
|
Sep 24
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
290
+0.43%
|
-
|
|
Sep 24
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
802
+0.29%
|
-
|
|
Sep 24
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
221
+0.37%
|
-
|
|
Sep 21
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
539
-0.81%
|
$6,468
$12.7 P/Share
|
|
Sep 10
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.26%
|
-
|
|
Sep 10
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
1,022
+0.24%
|
-
|
|
Sep 10
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
792
+0.29%
|
-
|
|
Sep 10
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
408
+0.61%
|
-
|
|
Sep 10
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
328
+0.56%
|
-
|
|
Aug 27
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
403
+0.32%
|
-
|
|
Aug 27
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
1,248
+0.3%
|
-
|
|
Aug 27
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
966
+0.35%
|
-
|
|
Aug 27
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.74%
|
-
|
|
Aug 27
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
401
+0.68%
|
-
|
|
Aug 25
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
347
-0.29%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
585
-0.88%
|
$5,850
$10.99 P/Share
|
|
Aug 25
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
410
-0.33%
|
$4,100
$10.99 P/Share
|
|
Aug 25
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
1,729
-0.41%
|
$17,290
$10.99 P/Share
|
|
Aug 25
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
519
-0.19%
|
$5,190
$10.99 P/Share
|
|
Aug 25
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
347
-0.82%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
347
-0.79%
|
$3,470
$10.99 P/Share
|
|
Aug 25
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
179
-0.31%
|
$1,790
$10.99 P/Share
|
|
Aug 14
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
277
-0.07%
|
$3,324
$12.38 P/Share
|
|
Aug 14
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
104
-0.24%
|
$1,248
$12.38 P/Share
|
|
Aug 14
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
156
-0.12%
|
$1,872
$12.38 P/Share
|
|
Aug 14
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
94
-0.14%
|
$1,128
$12.57 P/Share
|
|
Aug 14
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
109
-0.19%
|
$1,308
$12.57 P/Share
|
|
Aug 14
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
134
-0.11%
|
$1,608
$12.38 P/Share
|
|
Aug 14
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
180
-0.07%
|
$2,160
$12.38 P/Share
|
|
Aug 14
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
108
-0.25%
|
$1,296
$12.38 P/Share
|
|
Aug 09
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
58,465
+0.76%
|
$760,045
$13.2 P/Share
|
|
Jul 24
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
462
-1.04%
|
$8,778
$19.5 P/Share
|
|
Jul 24
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
679
-1.57%
|
$12,901
$19.5 P/Share
|
|
Jul 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.55%
|
$200,000
$20.07 P/Share
|
|
Jul 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Jul 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.55%
|
$200,000
$20.46 P/Share
|
|
Jul 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Jul 11
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
331
-0.76%
|
$7,282
$22.79 P/Share
|